RECOVERY & TISSUE REPAIR / COLOPHON
About This Bench Notebook
A citation-anchored bench log on the tissue-repair peptides — BPC-157, KLOW, KPV, and TB-500. Nothing sold, no one treated, no advice given.
What this bench notebook holds
Peptide R Lab is a bench notebook on four compounds studied in the recovery-and-tissue-repair space: BPC-157, KLOW, KPV, and TB-500, with TB-500 opening the notebook because its parent molecule carries the deepest human trial record of the four. The point is to make a scattered, often overstated literature legible — to set down plainly what each compound was actually studied for, in which species, and how far that evidence honestly reaches, before any anecdotal community reporting is layered on top.
The format is a working notebook, not a product catalog: every entry is logged in the same clinical order — what it is, how it is proposed to work, what the primary literature shows, what people report anecdotally, and what cautions the cited evidence genuinely supports. Logged together, the four reveal a pattern worth seeing clearly: three genuinely different repair mechanisms (angiogenesis, cell migration, anti-inflammatory signaling), one blend that packages three of them without ever being tested as a blend, and a human evidence base that runs, compound by compound, from thin to altogether absent.
How entries are logged
Two rules run this notebook. First, every research claim is logged against a numbered source on the references page — PubMed-indexed studies, a structural biology paper, and the field's one completed human Phase 1 trial, cited by bracketed number throughout. When a finding comes from a review rather than a primary study, or leaned on the full-length parent protein rather than the marketed fragment (TB-500's central caveat), that distinction is written down rather than smoothed over.
Second, evidence is logged at its actual strength, not its marketed strength. A two-person safety pilot is entered as a two-person safety pilot [1], not as proof of a therapeutic effect. A mouse colitis result is entered as a mouse colitis result [9], not as evidence for a human gut-health claim. What people report is kept in clearly labeled anecdotal paragraphs, walled off from anything a controlled study actually measured, and never pinned to a specific recommended dose.
What the notebook is not
A bench notebook is a record, not a pharmacy, a clinic, a telehealth platform, or a vendor of any kind. It sells, supplies, sources, and brokers nothing — no peptide, no research chemical — and holds no affiliate or referral tie to any research-chemical supplier. No clinician staffs it; nothing is diagnosed, and no dose, schedule, or route is put forward for any person.
None of the four compounds logged here — BPC-157, KLOW, KPV, or TB-500 — is an FDA-approved medicine. All are sold by research suppliers for laboratory use only, not for human consumption, and TB-500 is additionally barred from competitive sport by the World Anti-Doping Agency. Anyone seeking guidance on an injury, condition, or medication should consult a licensed healthcare provider. Notes on citation corrections or newly published research are welcome by way of the contact page; the notebook can't answer requests for medical advice.